Live News EQUITY FLASH M impact Nov 04, 2026, 01:04 PM UTC UroGen Pharma Q3 Revenue $89.001 Million vs. IBES Estimate $89.9 Million SquawkNews Desk 1 updates Updated Nov 04, 2026, 01:10 PM UTC Story updates 01:10:51 PM UTC SquawkNews UroGen Pharma Q3 revenue misses expectations on JELMYTO decline